Description
BridgeBio is hiring a full-time Skeletal Dysplasia Account Manager to lead the launch and commercial expansion of Infigratinib for achondroplasia across multiple Southwest territories. The role develops territory business plans, engages multidisciplinary healthcare providers and families, builds key-account relationships, supports KOL advocacy, and ensures compliance. Candidates need 8–10 years of pharmaceutical or biotech experience, including 4+ years in rare disease, genetic disease, or skeletal dysplasia, along with a BS/BA, extensive travel willingness, product-launch and account-management experience, and AI fluency. The role offers a $155,000–$210,000 USD salary range for California-based candidates, hybrid work flexibility, and comprehensive health benefits.
